Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-29

Clinical Trial Update: The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation

View source ↗

Summary

A completed clinical trial assessing the effectiveness of dual therapy with Lopinavir/ritonavir plus lamivudine in treatment-experienced HIV-1 infected patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)
  • Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: AbbVie | Conditions: HIV-1 Infection | Status: COMPLETED | Results posted: 2019-03-29